Clinical Trials
3 trialsNCT06764875 2026-05-12
A Phase â…¢ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
AstraZeneca
Phase 3 Recruiting
NCT06846996 2025-07-08
RECOVER
Daiichi Sankyo
Recruiting
NCT06572319 2024-08-27
Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
Zhejiang Cancer Hospital
Phase 1/2 Recruiting